The store will not work correctly when cookies are disabled.
ethyl 6-oxo-4,5,6,11-tetrahydro-2H-pyrrolo[3',4':5,6]azepino[4,3-b]indole-1-carboxylate
ID: ALA5285173
Max Phase: Preclinical
Molecular Formula: C17H15N3O3
Molecular Weight: 309.33
Associated Items:
Names and Identifiers
Canonical SMILES: CCOC(=O)c1[nH]cc2c1-c1[nH]c3ccccc3c1C(=O)NC2
Standard InChI: InChI=1S/C17H15N3O3/c1-2-23-17(22)15-12-9(7-18-15)8-19-16(21)13-10-5-3-4-6-11(10)20-14(12)13/h3-7,18,20H,2,8H2,1H3,(H,19,21)
Standard InChI Key: BWHNMECMUBMMQO-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
-2.5941 0.8336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8795 1.2459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1676 0.8340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1676 0.0088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8777 -0.4029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5941 0.0051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3828 -0.2461 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.3828 1.0889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1021 0.4213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9260 0.3849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4617 1.0115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3214 1.8170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5958 2.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.1627 1.8784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3563 -0.3180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2230 0.6957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1579 -0.1260 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.7462 2.4619 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.9437 -1.0326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3563 -1.7472 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.1185 -1.0326 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.1815 -1.7472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5941 -2.4619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
4 7 1 0
3 8 1 0
8 9 2 0
9 7 1 0
9 10 1 0
10 11 1 0
12 11 1 0
13 12 1 0
14 13 1 0
8 14 1 0
10 15 2 0
11 16 2 0
16 17 1 0
17 15 1 0
14 18 2 0
15 19 1 0
19 20 1 0
19 21 2 0
20 22 1 0
22 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 309.33 | Molecular Weight (Monoisotopic): 309.1113 | AlogP: 2.58 | #Rotatable Bonds: 2 |
Polar Surface Area: 86.98 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.66 | CX Basic pKa: ┄ | CX LogP: 1.82 | CX LogD: 1.82 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.64 | Np Likeness Score: 0.18 |
References
1. Akunuri R, Vadakattu M, Bujji S, Veerareddy V, Madhavi YV, Nanduri S.. (2021) Fused-azepinones: Emerging scaffolds of medicinal importance., 220 [PMID:33901899] [10.1016/j.ejmech.2021.113445] |